| |
Important Notice Regarding the Availability of Proxy Materials for the Stockholders’ Meeting to Be Held on July 26, 2022 at 10:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/ACCD2022.
|
| |
| |
The proxy statement and annual report to stockholders
are available at www.proxyvote.com. |
| |
| | You are cordially invited to attend the meeting online. Whether or not you expect to attend the meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote online if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. | | |
Proposals
|
| |
Page
|
| |
Voting Standard
|
| |
Board Recommendation
|
|
Election of Directors | | |
7
|
| | Plurality | | |
For each director nominee
|
|
Advisory approval of the compensation of the Company’s named executive officers | | |
19
|
| | Majority of shares present virtually or represented by proxy and entitled to vote on the matter | | |
For
|
|
Advisory vote on the frequency of stockholder advisory votes on executive compensation | | |
20
|
| | Majority of shares present virtually or represented by proxy and entitled to vote on the matter | | |
For One Year
|
|
Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for its fiscal year ending February 28, 2023 | | |
37
|
| | Majority of shares present virtually or represented by proxy and entitled to vote on the matter | | |
For
|
|
| LETTER FROM OUR CHIEF EXECUTIVE OFFICER | | | | | | | |
| | | | | 1 | | | |
| | | | | 7 | | | |
| | | | | 11 | | | |
| | | | | 11 | | | |
| | | | | 11 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 15 | | | |
| | | | | 15 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 22 | | | |
| | | | | 35 | | | |
| | | | | 38 | | | |
| | | | | 39 | | | |
| | | | | 41 | | | |
| | | | | 41 | | | |
| | | | | 41 | | | |
| | | | | 41 | | | |
| | | | | 41 | | | |
| | | | | 42 | | | |
| | | | | 43 | | |
| | Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers. | | |
|
Proposal
Number |
| |
Proposal Description
|
| |
Vote Required for Approval
|
| |
Effect of Abstentions
|
| |
Effect of Broker
Non-Votes |
|
|
1
|
| | Election of Directors | | | Nominees receiving the most “For” votes; withheld votes will have no effect | | | Not applicable | | | No effect | |
|
2
|
| | Advisory approval of the compensation of the Company’s named executive officers | | | “For” votes from the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter | | | Against | | | No effect | |
|
3
|
| | Advisory vote on the frequency of stockholder advisory votes on executive compensation | | | The frequency receiving the votes of the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter | | | Against each of the proposed voting frequencies | | | No effect | |
|
4
|
| | Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for its fiscal year ending February 28, 2023 | | | “For” votes from the holders of a majority of shares present virtually or represented by proxy and entitled to vote on the matter | | | Against | | |
Not applicable(1)
|
|
Name
|
| |
Age
|
| |
Director Since
|
| |
Principal Occupation/
Position Held With the Company |
|
Class II Directors – Nominees for Election at the 2022 Annual Meeting | | |||||||||
Mr. Thomas J. Neff | | | 84 | | | September 2007 | | | Director | |
Dr. Elizabeth Nabel | | | 70 | | | June 2021 | | | Director | |
Mr. Jeffrey Brodsky | | | 57 | | | June 2021 | | | Director | |
Name
|
| |
Age
|
| |
Director Since
|
| |
Principal Occupation/
Position Held With the Company |
| | | | ||||||
Class III Directors – Continuing in Office Until the 2023 Annual Meeting | | | | | |||||||||||||||
Mr. Rajeev Singh | | | 54 | | | October 2015 | | | Director, Chief Executive Officer and Chairman of the Board | | | | | ||||||
Mr. Peter Klein | | | 59 | | | September 2019 | | | Lead Independent Director | | | | | ||||||
Ms. Dawn Lepore | | | 68 | | | June 2019 | | | Director | | | | | ||||||
Ms. Patricia Wadors | | | 57 | | | February 2020 | | | Director | | | | | ||||||
Class I Directors – Continuing in Office Until the 2024 Annual Meeting | | | | | | | | | | | |||||||||
Mr. Jeffrey Jordan | | | 63 | | | July 2016 | | | Director | | | | | ||||||
Ms. Cindy Kent | | | 53 | | | January 2021 | | | Director | | | | |
Name
|
| |
Audit
|
| |
Compensation
|
| |
Nominating and
Corporate Governance |
| |||||||||
Mr. Jeffrey Brodsky(1)
|
| | | | | | | | | | X | | | | | | | | |
J. Michael Cline(2)
|
| | | | | | | | | | X | | | | | | | | |
William H. Frist(3)
|
| | | | | | | | | | | | | | | | | | |
Mr. Jeffrey Jordan
|
| | | | | | | | | | X | | | | | | | | |
Ms. Cindy Kent
|
| | | | | | | | | | | | | | | | X | | |
Mr. Peter Klein+
|
| | | | X* | | | | | | | | | | | | | | |
Ms. Dawn Lepore
|
| | | | X | | | | | | | | | | | | X* | | |
Dr. Elizabeth Nabel(4)
|
| | | | X | | | | | | | | | | | | | | |
Mr. Thomas J. Neff(5)
|
| | | | X | | | | | | X* | | | | | | | | |
Ms. Patricia Wadors
|
| | | | | | | | | | | | | | | | X | | |
Total meetings in the fiscal year ended February 28, 2022
|
| | | | 8 | | | | | | 4 | | | | | | 6 | | |
|
Board Diversity Matrix (As of April 18, 2022)
|
| ||||||
|
Total Number of Directors
|
| | |
|
9
|
| |
| | |
Female
|
| |
Male
|
| ||||||
Part I: Gender Identity
|
| | | | | | | | | | | | |
Directors
|
| | | | 4 | | | | | | 5 | | |
Part II: Demographic Background
|
| | | | | | | | | | | | |
African American or Black
|
| | | | 1 | | | | | | 0 | | |
Asian
|
| | | | 0 | | | | | | 1 | | |
White
|
| | | | 3 | | | | | | 4 | | |
Board Committee
|
| |
Chairperson
Fee |
| |
Member
Fee |
| ||||||
Audit Committee
|
| | | $ | 20,000 | | | | | $ | 10,000 | | |
Compensation Committee
|
| | | | 10,000 | | | | | | 5,000 | | |
Nominating and Corporate Governance Committee
|
| | | | 10,000 | | | | | | 5,000 | | |
Name
|
| |
Fees Earned or
Paid in Cash ($) |
| |
Stock Awards
($)(1)(2) |
| |
Total
($) |
| |||||||||
Mr. Jeffrey Brodsky(3)
|
| | | | 86,800 | | | | | | 148,007 | | | | | | 234,807 | | |
J. Michael Cline(4)
|
| | | | 8,750 | | | | | | 24,608 | | | | | | 33,358 | | |
William H. Frist(5)
|
| | | | — | | | | | | 24,608 | | | | | | 24,608 | | |
Mr. Jeffrey Jordan
|
| | | | 91,800(6) | | | | | | 130,200 (6) | | | | | | 222,000 | | |
Ms. Cindy Kent
|
| | | | 91,800 | | | | | | 130,200 | | | | | | 222,000 | | |
Mr. Peter Klein
|
| | | | 106,800 | | | | | | 130,200 | | | | | | 237,000 | | |
Ms. Dawn Lepore
|
| | | | 106,800(6) | | | | | | 130,200 (6) | | | | | | 237,000 | | |
Dr. Elizabeth Nabel(7)
|
| | | | 86,800 | | | | | | 148,007 | | | | | | 234,807 | | |
Mr. Thomas J. Neff
|
| | | | 106,800(6) | | | | | | 130,200 (6) | | | | | | 237,000 | | |
Ms. Patricia Wadors
|
| | | | 91,800(6) | | | | | | 130,200(6) | | | | | | 222,000 | | |
Name
|
| |
Age
|
| |
Position
|
|
Stephen Barnes | | |
51
|
| | Chief Financial Officer | |
Robert Cavanaugh | | |
53
|
| | President | |
Michael Hilton | | |
58
|
| | Chief Innovation Officer | |
|
Fiscal Year 2022 Peer Group
|
| |||||||||
|
1Life Healthcare
|
| |
Benefitfocus
|
| |
HealthEquity
|
| |
Phreesia
|
|
|
American Well
|
| |
Castlight Health
|
| |
HealthStream
|
| |
Progyny
|
|
|
AppFolio
|
| |
GoodRx Holdings
|
| |
Model N
|
| |
Tabula Rasa HealthCare
|
|
|
Avalara
|
| |
Health Catalyst
|
| |
NRC Health
|
| |
Yext
|
|
Name
|
| |
Fiscal Year 2021 Base
Salary Rate ($) (Effective June 1, 2020) |
| |
Fiscal Year 2022 Base
Salary Rate ($) (Effective June 1, 2021) |
| |
Fiscal Year 2022 Base
Salary Earnings ($) |
| |||||||||
Rajeev Singh
|
| | | | 400,000 | | | | | | 500,000 | | | | | | 470,769 | | |
Stephen H. Barnes
|
| | | | 360,000 | | | | | | 400,000 | | | | | | 388,308 | | |
Robert Cavanaugh
|
| | | | 375,000 | | | | | | 410,000 | | | | | | 399,769 | | |
Michael Hilton
|
| | | | 350,000 | | | | | | 400,000 | | | | | | 385,384 | | |
| | |
Incentive Opportunity as % of Base Salary(1)
|
| | | | | | | |||||||||||||||
Name
|
| |
Target
(3/1/21-5/31/21) |
| |
Target
(6/1/21-2/28/22) |
| |
Maximum
|
| |
Target Bonus ($)(2)
|
| ||||||||||||
Rajeev Singh
|
| | | | 85 | | | | | | 100 | | | | | | 125 | | | | | | 454,615 | | |
Stephen H. Barnes
|
| | | | 55 | | | | | | 70 | | | | | | 125 | | | | | | 257,277 | | |
Robert Cavanaugh
|
| | | | 70 | | | | | | 75 | | | | | | 125 | | | | | | 294,779 | | |
Michael Hilton
|
| | | | 55 | | | | | | 70 | | | | | | 125 | | | | | | 255,635 | | |
Performance Goal
|
| |
Weighting
|
| |
Threshold
|
| |
Target
|
| |
Maximum
|
| |
Actual Performance
|
|
Revenue(1)
|
| |
20%
|
| |
$274.5 million
|
| |
$305.0 million
|
| |
$457.7 million
|
| |
$310.0 million
|
|
New Bookings (ARR)(2)
|
| |
20%
|
| |
61.2 million
|
| |
$76.5 million
|
| |
$114.75 million
|
| |
$54.2 million
|
|
Adjusted EBITDA(3)
|
| |
20%
|
| |
$(58.3) million
|
| |
$(53.0) million
|
| |
$(53.0) million
|
| |
$(42.4) million
|
|
Adjusted Gross Margin(4)
|
| |
20%
|
| |
42.55%
|
| |
44.8%
|
| |
44.8%
|
| |
46.5%
|
|
Member Satisfaction(5)
|
| |
20%
|
| |
72 / 64/ 64
|
| |
90 / 80/ 80
|
| |
100 / 100 / 100
|
| |
92/91/87
|
|
Performance Goal
|
| |
Achievement (%)
|
| |||
Revenue
|
| | | | 101.61 | | |
New Bookings (ARR)
|
| | | | — | | |
Adjusted EBITDA
|
| | | | 100 | | |
Adjusted Gross Margin
|
| | | | 100 | | |
Member Satisfaction
|
| | | | 109 | | |
Total Achievement
|
| | | | 82.15% | | |
Name
|
| |
Fiscal Year 2022
Annual Incentive Payout Percentage (% of Target) |
| |
Fiscal Year 2022
Annual Bonus ($)(1) |
| ||||||
Rajeev Singh
|
| | | | 82.15% | | | | | | 373,467 | | |
Stephen H. Barnes
|
| | | | 82.15% | | | | | | 211,353 | | |
Robert Cavanaugh
|
| | | | 82.15% | | | | | | 242,161 | | |
Michael Hilton
|
| | | | 82.15% | | | | | | 210,004 | | |
Name
|
| |
Performance-based
Restricted Stock Units (# at Target) |
| |||
Rajeev Singh
|
| | | | 20,194 | | |
Stephen H. Barnes
|
| | | | 11,309 | | |
Robert Cavanaugh
|
| | | | 12,419 | | |
Michael Hilton
|
| | | | 11,309 | | |
Name
|
| |
Restricted
Stock Units (#) |
| |
Shares Underlying
Option Grant (#) |
| ||||||
Rajeev Singh
|
| | | | 44,776 | | | | | | 89,552 | | |
Stephen H. Barnes
|
| | | | 19,900 | | | | | | 39,800 | | |
Robert Cavanaugh
|
| | | | 24,478 | | | | | | 48,955 | | |
Michael Hilton
|
| | | | 15,920 | | | | | | 31,841 | | |
Name
|
| |
Fiscal
Year |
| |
Salary
($) |
| |
Stock
Awards ($)(1) |
| |
Option
Awards ($)(2) |
| |
Non-Equity
Incentive Plan Compensation ($)(3) |
| |
All Other
Compensation ($)(4) |
| |
Total
($) |
| ||||||||||||||||||
Rajeev Singh
Chief Executive Officer |
| |
2022
|
| | | | 470,769 | | | | | | 2,390,143 | | | | | | 2,861,124 | | | | | | 373,467 | | | | | | 3,000 | | | | | | 6,027,734 | | |
|
2021
|
| | | | 400,000 | | | | | | — | | | | | | 1,764,000 | | | | | | 425,000 | | | | | | 3,000 | | | | | | 2,592,000 | | | ||
|
2020
|
| | | | 394,231 | | | | | | — | | | | | | 2,553,600 | | | | | | 194,167 | | | | | | 3,000 | | | | | | 3,144,998 | | | ||
Stephen H. Barnes
Chief Financial Officer |
| |
2022
|
| | | | 388,307 | | | | | | 1,062,262 | | | | | | 1,271,614 | | | | | | 211,353 | | | | | | 3,000 | | | | | | 2,908,229 | | |
|
2021
|
| | | | 360,000 | | | | | | — | | | | | | 1,176,000 | | | | | | 247,600 | | | | | | 3,000 | | | | | | 1,786,600 | | | ||
|
2020
|
| | | | 358,846 | | | | | | — | | | | | | 648,000 | | | | | | 115,716 | | | | | | 3,000 | | | | | | 1,125,562 | | | ||
Robert Cavanaugh
President |
| |
2022
|
| | | | 399,769 | | | | | | 1,306,636 | | | | | | 1,564,078 | | | | | | 242,161 | | | | | | 3,000 | | | | | | 3,490,875 | | |
|
2021
|
| | | | 375,000 | | | | | | — | | | | | | 1,176,000 | | | | | | 328,125 | | | | | | 3,000 | | | | | | 1,882,125 | | | ||
|
2020
|
| | | | 372,115 | | | | | | — | | | | | | 960,000 | | | | | | 152,010 | | | | | | 3,000 | | | | | | 1,487,125 | | | ||
Michael Hilton
Chief Innovation Officer |
| |
2022
|
| | | | 385,385 | | | | | | 849,810 | | | | | | 1,017,298 | | | | | | 210,004 | | | | | | 3,000 | | | | | | 2,430,112 | | |
|
2021
|
| | | | 350,000 | | | | | | — | | | | | | 708,352 | | | | | | 240,625 | | | | | | 3,000 | | | | | | 1,301,977 | | | ||
|
2020
|
| | | | 347,115 | | | | | | — | | | | | | 696,000 | | | | | | 111,348 | | | | | | 3,000 | | | | | | 1,157,463 | | |
| | | | | |
Estimated Future Payouts Under
Non-Equity Incentive Plan Awards(1) |
| |
All Other
Stock Awards: Number of Shares of Stock or Units (#) |
| |
All Other
Option Awards: Number of Securities Underlying Options (#) |
| |
Exercise or
base price of option awards ($/Sh) |
| |
Grant
Date Fair Value of Stock and Option Awards ($)(4) |
| |||||||||||||||||||||
Name
|
| |
Grant
Date |
| |
Target
($) |
| |
Maximum
($) |
| ||||||||||||||||||||||||||||||
Rajeev Singh
|
| |
N/A
|
| | | | 454,615 | | | | | | 588,461 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 6/16/2021 | | | | | | | | | | | | | | | | | 44,776(2) | | | | | | | | | | | | | | | | | | 2,390,143 | | | ||
| 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | 89,552(3) | | | | | | 53.38 | | | | | | 2,861,124 | | | ||
Stephen H. Barnes
|
| |
N/A
|
| | | | 257,277 | | | | | | 485,385 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 6/16/2021 | | | | | | | | | | | | | | | | | 19,900(2) | | | | | | | | | | | | | | | | | | 1,062,262 | | | ||
| 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | 39,800(3) | | | | | | 53.38 | | | | | | 1,271,614 | | | ||
Robert Cavanaugh
|
| |
N/A
|
| | | | 294,779 | | | | | | 499,711 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 6/16/2021 | | | | | | | | | | | | | | | | | 24,478(2) | | | | | | | | | | | | | | | | | | 1,306,636 | | | ||
| 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | 48,955(3) | | | | | | 53.38 | | | | | | 1,564,078 | | | ||
Michael Hilton
|
| |
N/A
|
| | | | 255,635 | | | | | | 481,730 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 6/16/2021 | | | | | | | | | | | | | | | | | 15,920(2) | | | | | | | | | | | | | | | | | | 849,810 | | | ||
| 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | 31,841(3) | | | | | | 53.38 | | | | | | 1,017,298 | | |
| | | | | | | | |
Option Awards
|
| |
Stock Awards
|
| ||||||||||||||||||||||||||||||||||||||||||
Name
|
| |
Grant Date
|
| |
Number of
Securities Underlying Unexercised Options Exercisable |
| |
Number of
Securities Underlying Options Unexercisable(1)(2) |
| |
Option
Exercise Price ($)(3) |
| |
Option
Expiration Date |
| |
Number of
Shares or Units of Stock that Have Not Vested (#) |
| |
Market
Value of Shares or Units of Stock that Have Not Vested ($)(4) |
| |
Number of
Unearned Shares, Units, or Other Rights that Have Not Vested ($) |
| |
Market of
Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($) |
| |||||||||||||||||||||||||||
Rajeev Singh
|
| | | | 10/30/2015 | | | | | | 1,600,000 | | | | | | —(a) | | | | | | 4.20 | | | | | | 10/30/2025 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 7/26/2017 | | | | | | 30,000 | | | | | | —(b) | | | | | | 4.50 | | | | | | 7/26/2027 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 5/3/2018 | | | | | | 28,750 | | | | | | 1,250(c) | | | | | | 4.70 | | | | | | 5/2/2028 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/25/2019 | | | | | | 354,666 | | | | | | 177,334(e) | | | | | | 9.60 | | | | | | 6/24/2029 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/17/2020 | | | | | | 80,346 | | | | | | 87,500(f) | | | | | | 17.50 | | | | | | 6/16/2030 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | — | | | | | | 89,552(h) | | | | | | 53.38 | | | | | | 6/15/2031 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 44,776(5) | | | | | | 805,072 | | | | | | — | | | | | | — | | | ||
Stephen H. Barnes
|
| | | | 2/1/2015 | | | | | | 156,000 | | | | | | —(g) | | | | | | 4.20 | | | | | | 2/1/2025 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 4/26/2017 | | | | | | 15,000 | | | | | | —(d) | | | | | | 4.20 | | | | | | 4/26/2027 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 5/3/2018 | | | | | | 8,145 | | | | | | 355(c) | | | | | | 4.70 | | | | | | 5/2/2028 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/25/2019 | | | | | | 90,000 | | | | | | 45,000(e) | | | | | | 9.60 | | | | | | 6/24/2029 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/17/2020 | | | | | | 52,301 | | | | | | 58,334(f) | | | | | | 17.50 | | | | | | 6/16/2030 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | — | | | | | | 39,800(h) | | | | | | 53.38 | | | | | | 6/15/2031 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 19,900(5) | | | | | | 357,802 | | | | | | — | | | | | | — | | | ||
Robert Cavanaugh
|
| | | | 10/30/2015 | | | | | | 564,750 | | | | | | —(a) | | | | | | 4.20 | | | | | | 10/30/2025 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 4/26/2017 | | | | | | 15,000 | | | | | | —(d) | | | | | | 4.20 | | | | | | 4/26/2027 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 5/3/2018 | | | | | | 8,145 | | | | | | 355(c) | | | | | | 4.70 | | | | | | 5/2/2028 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/25/2019 | | | | | | 133,333 | | | | | | 66,667(e) | | | | | | 9.60 | | | | | | 6/24/2029 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/17/2020 | | | | | | 55,637 | | | | | | 58,334(f) | | | | | | 17.50 | | | | | | 6/16/2030 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | — | | | | | | 48,955(h) | | | | | | 53.38 | | | | | | 6/15/2031 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 24,478(5) | | | | | | 440,114 | | | | | | — | | | | | | — | | | ||
Michael Hilton
|
| | | | 10/30/2015 | | | | | | 502,000 | | | | | | —(a) | | | | | | 4.20 | | | | | | 10/30/2025 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 4/26/2017 | | | | | | 20,000 | | | | | | —(d) | | | | | | 4.20 | | | | | | 4/26/2027 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 5/3/2018 | | | | | | 8,145 | | | | | | 355(c) | | | | | | 4.70 | | | | | | 5/2/2028 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/25/2019 | | | | | | 96,666 | | | | | | 48,334(e) | | | | | | 9.60 | | | | | | 6/24/2029 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/17/2020 | | | | | | 31,067 | | | | | | 29,167(f) | | | | | | 17.50 | | | | | | 6/16/2030 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | — | | | | | | 31,841(h) | | | | | | 53.38 | | | | | | 6/15/2031 | | | | | | | | | | | | | | | | | | | | | | | | | | | ||
| | | 6/16/2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 15,920(5) | | | | | | 286,242 | | | | | | — | | | | | | — | | |
Name
|
| |
Cash
Severance ($) |
| |
Benefit
Continuation ($) |
| |
Equity
Awards ($)(2) |
| |
Total
($) |
| ||||||||||||
Rajeev Singh | | | | | | | | | | | | | | | | | | | | | | | | | |
Termination except for cause
|
| | | | 500,000 | | | | | | — | | | | | | 1,153,232 | | | | | | 1,653,232 | | |
Termination in connection with change in control(1)
|
| | | | 500,000 | | | | | | — | | | | | | 2,349,761 | | | | | | 2,849,731 | | |
Stephen H. Barnes | | | | | | | | | | | | | | | | | | | | | | | | | |
Termination except for cause
|
| | | | 400,000 | | | | | | 17,232 | | | | | | — | | | | | | 417,232 | | |
Termination in connection with change in control(1)
|
| | | | 400,000 | | | | | | — | | | | | | 767,617 | | | | | | 1,167,617 | | |
Robert Cavanaugh | | | | | | | | | | | | | | | | | | | | | | | | | |
Termination in connection with change in control(1)
|
| | | | — | | | | | | — | | | | | | 1,031,499 | | | | | | 1,031,499 | | |
Michael Hilton | | | | | | | | | | | | | | | | | | | | | | | | | |
Termination in connection with change in control(1)
|
| | | | — | | | | | | — | | | | | | 709,995 | | | | | | 709,995 | | |
| | |
Fiscal Year Ended February 28
|
| |||||||||
| | |
2022
|
| |
2021
|
| ||||||
Audit Fees(1)
|
| | | $ | 2,824,500 | | | | | $ | 2,380,000 | | |
Audit-related Fees
|
| | | | — | | | | | | — | | |
Tax Fees(2)
|
| | | | 58,096 | | | | | | 81,170 | | |
All Other Fees
|
| | | | — | | | | | | — | | |
Total Fees
|
| | |
$
|
2,882,596
|
| | | |
$
|
2,461,170
|
| |
Name of beneficial owner
|
| |
Number of
shares beneficially owned |
| |
Percentage
of Shares Beneficially Owned |
| ||||||
5% and Greater Stockholders: | | | | | | | | | | | | | |
Entities affiliated with Andreessen Horowitz(1)
|
| | | | 5,398,708 | | | | | | 7.7% | | |
ARK Investment Management LLC(2)
|
| | | | 6,309,958 | | | | | | 9.0 | | |
The Vanguard Group(3)
|
| | | | 5,040,150 | | | | | | 7.2 | | |
Executive Officers and Directors: | | | | | | | | | | | | | |
Rajeev Singh(4)
|
| | | | 2,901,817 | | | | | | 4.0 | | |
Robert Cavanaugh(5)
|
| | | | 967,348 | | | | | | 1.4 | | |
Stephen Barnes(6)
|
| | | | 430,843 | | | | | | * | | |
Michael Hilton(7)
|
| | | | 1,012,135 | | | | | | 1.4 | | |
Jeffrey Brodsky(8)
|
| | | | 4,212 | | | | | | * | | |
Jeffrey Jordan(9)
|
| | | | 4,503 | | | | | | * | | |
Cindy Kent(10)
|
| | | | 4,019 | | | | | | * | | |
Peter Klein(11)
|
| | | | 21,907 | | | | | | * | | |
Dawn Lepore(12)
|
| | | | 19,895 | | | | | | * | | |
Elizabeth Nabel(13)
|
| | | | 3,005 | | | | | | * | | |
Thomas Neff(14)
|
| | | | 42,472 | | | | | | * | | |
Patricia Wadors(15)
|
| | | | 16,169 | | | | | | * | | |
All executive officers and directors as a group (12 persons)(16)
|
| | | | 5,428,325 | | | | | | 7.3 | | |
Plan Category
|
| |
(a) Number of
securities to be issued upon exercise of outstanding options |
| |
(b) Weighted-
average exercise price of outstanding options(1) |
| |
(c) Number of
securities remaining available for issuance under equity compensation plans (excluding securities reflected in column (a)) |
| |||||||||
Equity compensation plans approved by security holders
|
| | | | | | | | | | | | | | | | | | |
Amended and Restated 2007 Stock Option Plan
|
| | | | 7,514,240 | | | | | | 8.68 | | | | | | — | | |
2020 Equity Incentive Plan(2)(3)
|
| | | | 2,757,609 | | | | | | 47.44 | | | | | | 3,682,077 | | |
2020 Employee Stock Purchase Plan(4)
|
| | | | — | | | | | | — | | | | | | 1,448,655 | | |
PlushCare, Inc. Stock Incentive Plan
|
| | | | 267,721 | | | | | | 1.65 | | | | | | — | | |
Equity compensation plans not approved by security holders
|
| | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | | 10,539,570 | | | | | $ | 18.64 | | | | | | 5,130,732 | | |